Adjunctive Photodynamic Therapy + Aflibercept vs. Afilbercept Alone for PDA in NV AMD

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 31, 2016

Primary Completion Date

January 31, 2018

Study Completion Date

January 31, 2018

Conditions
Neovascular Age-related Macular Degeneration
Interventions
DRUG

Aflibercept

Aflibercept is a recombinant fusion protein consisting of portions of human VEGF receptors 1 and 2 extracellular domains fused to the Fc portion of human IgG1.

DRUG

Triamcinolone Acetonide

Triamcinolone Acetonide is a synthetic corticosteroid indicated for treatment of ocular inflammatory conditions, uveitis, sympathetic ophthalmia, and temporal arteritis.

DRUG

Verteporfin

Verteporfin is a benzoporphyrin derivative, and is a medication used as a photosensitizer for photodynamic therapy.

Trial Locations (1)

27710

Duke Eye Center, Durham

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Bausch & Lomb Incorporated

INDUSTRY

lead

Duke University

OTHER